Klasse PJ - Search Results

1

Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.

Ringe RP, Colin P, Ozorowski G, Allen JD, Yasmeen A, Seabright GE, Lee JH, Antanasijevic A, Rantalainen K, Ketas T, Moore JP, Ward AB, Crispin M, Klasse PJ. Ringe RP, et al. Among authors: klasse pj. PLoS Pathog. 2023 Oct 30;19(10):e1011601. doi: 10.1371/journal.ppat.1011601. eCollection 2023 Oct. PLoS Pathog. 2023. PMID: 37903160 Free PMC article.

2

A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and HIV-1 infection of CD4+ cells.

Moore JP, Sattentau QJ, Klasse PJ, Burkly LC. Moore JP, et al. Among authors: klasse pj. J Virol. 1992 Aug;66(8):4784-93. doi: 10.1128/JVI.66.8.4784-4793.1992. J Virol. 1992. PMID: 1378510 Free PMC article.

3

Kinetics of the HIV-CD4 interactions and virus-cell fusion.

Klasse PJ, Moore JP. Klasse PJ, et al. AIDS. 1992 Mar;6(3):325-7. doi: 10.1097/00002030-199203000-00011. AIDS. 1992. PMID: 1567578 No abstract available.

4

Thermodynamic and kinetic analysis of sCD4 binding to HIV-1 virions and of gp120 dissociation.

Moore JP, Klasse PJ. Moore JP, et al. Among authors: klasse pj. AIDS Res Hum Retroviruses. 1992 Apr;8(4):443-50. doi: 10.1089/aid.1992.8.443. AIDS Res Hum Retroviruses. 1992. PMID: 1599754

5

Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency virus type 1 gp120 block CD4 binding in vitro.

Cordell J, Moore JP, Dean CJ, Klasse PJ, Weiss RA, McKeating JA. Cordell J, et al. Among authors: klasse pj. Virology. 1991 Nov;185(1):72-9. doi: 10.1016/0042-6822(91)90755-z. Virology. 1991. PMID: 1718090

6

Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1.

Klasse PJ, Moore JP. Klasse PJ, et al. J Virol. 1996 Jun;70(6):3668-77. doi: 10.1128/JVI.70.6.3668-3677.1996. J Virol. 1996. PMID: 8648701 Free PMC article.

7

Entry inhibitors SCH-C, RANTES, and T-20 block HIV type 1 replication in multiple cell types.

Ketas TJ, Klasse PJ, Spenlehauer C, Nesin M, Frank I, Pope M, Strizki JM, Reyes GR, Baroudy BM, Moore JP. Ketas TJ, et al. Among authors: klasse pj. AIDS Res Hum Retroviruses. 2003 Mar;19(3):177-86. doi: 10.1089/088922203763315678. AIDS Res Hum Retroviruses. 2003. PMID: 12689409

8

Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection.

Veazey RS, Klasse PJ, Ketas TJ, Reeves JD, Piatak M Jr, Kunstman K, Kuhmann SE, Marx PA, Lifson JD, Dufour J, Mefford M, Pandrea I, Wolinsky SM, Doms RW, DeMartino JA, Siciliano SJ, Lyons K, Springer MS, Moore JP. Veazey RS, et al. Among authors: klasse pj. J Exp Med. 2003 Nov 17;198(10):1551-62. doi: 10.1084/jem.20031266. J Exp Med. 2003. PMID: 14623909 Free PMC article.

9

Is there enough gp120 in the body fluids of HIV-1-infected individuals to have biologically significant effects?

Klasse PJ, Moore JP. Klasse PJ, et al. Virology. 2004 May 20;323(1):1-8. doi: 10.1016/j.virol.2004.03.003. Virology. 2004. PMID: 15165814 Free article. Review. No abstract available.

10

Recombinant gp120, antibodies to the V3 region of gp120, and neural progenitor cells.

Klasse PJ, Barnes KC, Moore JP. Klasse PJ, et al. J Infect Dis. 2005 Mar 1;191(5):815-6; author reply 816-8. doi: 10.1086/427195. J Infect Dis. 2005. PMID: 15688301 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters